News | May 21, 2015

Latest version supports planning for multiple patients simultaneously across multiple treatment techniques

Elekta, Monaco, v5.10, CE Mark

May 21, 2015 — Elekta has CE marked the latest version (v5.10) of its popular Monaco treatment planning system, enabling its sale to European clinics. The system supports major treatment techniques including advanced 3-D planning, intensity modulated radiation therapy (IMRT), volumetric arc therapy (VMAT) and stereotactic planning – all in a single system.

Monaco v5.10 provides significant planning and quality assurance (QA) enhancements, as well improved workflow efficiency. Advancements in 3-D planning as well as the addition of magnetic resonance imaging (MRI) and forward planning capabilities further reinforces Monaco as a robust and flexible treatment planning solution. Now, users can simplify their planning with advanced time-saving tools, speed up workflow and ultimately create better plans with fewer contours and therefore less variability.

Furthermore, utilizing the Monte Carlo algorithm, Monaco now enables users to recalculate third-party plans for quality assurance checks.

Key Monaco v5.10 benefits designed to improve planning time enable clinicians to:

  • Optimize plan creation with customizable templates that can be shared across institutions;
  • Plan multiple patients simultaneously;
  • Achieve better dose conformity with state-of-the art optimization tools;
  • Create multiple prescriptions within a single active plan; and
  • Quickly learn and use the system through its modern, intuitive interface.

 

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now